image
Cytokinetics, Incorporated CYTK
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 35.25
0.313 %
$ 4.21 B
Market Cap
-6.66
P/E
Price Target Average
114.18%
Revenue Forecast Estimate
198.06%
EBIT Estimate
--28.41%
Net Income Estimate
24.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Cytokinetics, Incorporated
image
Wall Street analysts predict an average 1-year price target for CYTK of $75.5 , with forecasts ranging from a low of $55 to a high of $120 .
CYTK Lowest Price Target Wall Street Target
55 USD 56.03%
CYTK Average Price Target Wall Street Target
75.5 USD 114.18%
CYTK Highest Price Target Wall Street Target
120 USD 240.43%
Price
Max Price Target
Min Price Target
Average Price Target
12012011011010010090908080707060605050404030302020Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart CYTK

image
$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CYTK

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)($1.6b)($1.6b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CYTK

image
$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029